Results
|
57901.
|
|
|
57902.
|
|
|
57903.
|
|
|
57904.
|
|
|
57905.
|
|
|
57906.
|
|
|
57907.
|
|
|
57908.
|
|
|
57909.
|
|
|
57910.
|
|
|
57911.
|
|
|
57912.
|
|
|
57913.
|
Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trial. [electronic resource] by
- James, Nicholas D
- Caty, Armelle
- Payne, Heather
- Borre, Michael
- Zonnenberg, Bernard A
- Beuzeboc, Philippe
- McIntosh, Stuart
- Morris, Thomas
- Phung, De
- Dawson, Nancy A
Producer: 20101103
In:
BJU international vol. 106
Availability: No items available.
|
|
57914.
|
|
|
57915.
|
|
|
57916.
|
|
|
57917.
|
|
|
57918.
|
|
|
57919.
|
|
|
57920.
|
|